CureVac COVID-19 vaccine

Rarity: Common

The most frequent rarity: most Wikipedia articles become Commons.

Rarity follows how well known the article is: its views on the French and English Wikipedia over a year, and the number of languages it exists in.

At a glance

Class

Notion

Domain

Science and technology

In collections

Nobody has pulled it yet.

What Wikipedia says

The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness Innovations (CEPI). The vaccine showed inadequate results in its Phase III trials with only 47% efficacy.

Excerpt from the Wikipedia article “CureVac COVID-19 vaccine”, under the CC BY-SA 4.0 license. Read the article on Wikipedia

Image: Alexey Solodovnikov (Idea, Producer, CG, Editor), Valeria Arkhipova (Scientific Сonsultant), CC BY-SA 4.0, via Wikimedia Commons.